DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20202296

Steroid induced psychiatric adverse effects: an overview of risk factors, clinical features and management

Anant Parasher, Jeplin Bez

Abstract


Corticosteroids have been in use since the past five decades as anti-inflammatory and immunosuppressive drugs for the treatment of several pathologies such as asthma, allergy, rheumatoid arthritis, and dermatological disorders. Adverse effects include growth retardation in children, immunosuppression, hypertension, hyperglycemia, inhibition of wound repair, osteoporosis, metabolic disturbances, glaucoma, and cataracts. The psychiatric effects of steroids are due to the wide expression of Glucocorticoid Receptors in the brain, and their long-term modulation can lead to functional and anatomical alterations along with hippocampal dysfunction. In most cases, the psychiatric symptoms disappear on cessation of steroid therapy; others may require some form of therapeutic management. A search was conducted for clinically relevant articles from 1971 to 2016 by including the terms corticosteroids, mania, depression, psychosis and cognitive defects. About one-fifth of patients receiving high doses of corticosteroids develop psychiatric symptoms. These symptoms are observed to be dose-dependent and generally occur during the first few weeks of therapy. Lithium has a preventive as well as therapeutic role, while antipsychotics are reserved for high risk cases with predominant psychotic symptoms. Psychiatric effects of long term steroid therapy have become increasingly common nowadays due to long duration of treatment of many chronic respiratory and orthopedic illnesses. Reduction in the dose or complete discontinuation of steroid therapy has been proven beneficial in many patients. Among the therapeutic options, lithium has a definitive role, both in the prevention as well as treatment of psychiatric symptoms. Better co-ordination between the physician and psychiatrist can go a long way to improve the quality of life in these patients.

 


Keywords


Cognitive deficits, Corticosteroids, Depression, Mania, Psychosis

Full Text:

PDF

References


Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, et al. Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacotherapeut. 2013 Dec;4(Suppl1):S94-8.

Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clini Pharmacol Therap. 1972 Sep;13(5part1):694-8.

Wolkowitz OM. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinol. 1994 Jan 1;19(3):233-55.

Zagaria MA. Systemic Corticosteroid–Associated Psychiatric Adverse Effects. US Pharm. 2016;41(7):16-18.

Cerullo MA. Corticosteroid-induced mania: Prepare for the unpredictable. Curr Psychiatry. June 2006. Available at: www.currentpsychiatry.com/index.php?id=22661&tx_ttnews[tt_news]=171412. Accessed 22 June 2016.

Brown ES, Suppes T, Khan DA, Carmody III TJ. Mood changes during prednisone bursts in outpatients with asthma. J Clini Psychopharmacol. 2002 Feb 1;22(1):55-61.

Goldstein ET, Preskorn SH. Mania triggered by a steroid nasal spray in a patient with stable bipolar disorder. Am J Psychiatr. 1989;146:1076-7.

George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol. 2004 Aug 1;140(8):963-9.

Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Aller, Asthma Immunol. 2004 May 1;92(5):500-5.

Lewis GP, Jusko WJ, Burke CW, Graves L. The Boston Collaborative Drug Surveillance Program: prednisolone side effects and serum protein levels. Lancet. 1971;2:779-81.

Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clini Proceed. 2006 Oct 1;81(10):1361-1367.

Lewis DA, Smith RE. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affective Disord. 1983 Nov 1;5(4):319-32.

Fietta P, Fietta P, Delsante G. Central nervous system effects of natural and synthetic glucocorticoids. Psychiatr Clini Neurosci. 2009 Oct;63(5):613-22.

Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Therap. 2002 Oct 1;96(1):23-43.

Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psych. 2012 May;169(5):491-7.

Falk WE, Mahnke MW, Poskanzer DC. Lithium Prophylaxis of Corticotropin-lnduced Psychosis. JAMA. 1979 Mar 9;241(10):1011-2.

Hall RC, Popkin MK, Kirkpatrick B. Brief communication: Tricyclic Exacerbation Of Steroid Psychosis. J Nervous Mental Dis. 1978 Oct 1;166(10):738-42.

Gagliardi JP. Corticosteroid psychosis: Stop therapy or add psychotropics?. Curr Psychi. 2010 Jan;9:61-9.

Sirois F. Steroid psychosis: a review. Gen Hosp Psych. 2003 Jan 1;25(1):27-33.

Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci. 1994 Apr 1;14(4):2047-53.

Swinburn CR, Wakefield JM, Newman SP, Jones PW. Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease. Br J Clini Pharmacol. 1988 Dec;26(6):709-13.

Varney NR, Alexander B, MacIndoe JH. Reversible steroid dementia in patients without steroid psychosis. Am J Psych. 1984 Mar;141:369–372.

Stoudemire A, Anfinson T, Edwards J. Corticosteroid-induced delirium and dependency. Gen Hosp Psych. 1996 May 1;18(3):196-202.

Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA, et al. Prednisone effects on neurochemistry and behavior: preliminary findings. Arch Gen Psych. 1990 Oct 1;47(10):963-8.

Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psych. 1999 Jun 1;56(6):527-33.

Brown ES, Rush AJ, McEwen BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacol. 1999 Oct;21(4):474-84.

De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998 Jun 1;19(3):269-301.

Hall RC, Popkin MK, Stickney SK, Gardner ER. Presentation of the steroid psychoses. J Nerv Mental Dis. 1979 Apr;167:229-236.

Khan DA, Brown ES, Suppes P, Carmody TJ. Mood changes during prednisone bursts for asthma. Am J Respir Crit Care Med. 1999;159(3):A919.

Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S. Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J Clini Psychiatry. 2000 Apr;61(4):261-7.

McEwen BS. Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity. Neurochem res. 2000 Oct 1;25(9-10):1219-31.

Ling MH, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy: psychiatric aspects. Archi Gen Psych. 1981 Apr 1;38(4):471-7.

Fardet L, Nazareth I, Whitaker HJ, Petersen I. Severe neuropsychiatric outcomes following discontinuation of long-term glucocorticoid therapy: a cohort study. J Clin Psychiatry. 2013;74(4):e281-6.

Brown ES, Chandler PA. Mood and Cognitive Changes During Systemic Corticosteroid Therapy. Prim Care Compan J Clin Psych. 2001;3(1):17-21.

Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, et al. Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosom. 2001 Nov 1;42(6):461-6.

Bender BG, Lerner JA, Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psych. 1988 Nov 1;27(6):720-5.

Gagliardi JP, Muzyk AJ, Holt S. When steroids cause psychosis. Available at: www.the-rheumatologist.org/article/when-steroids-cause-psychosis. Accessed 9 June 2016.

Kemp K, Lion JR, Magram G. Lithium in the treatment of a manic patient with multiple sclerosis: a case report. Dis Nerv Syst. 1977 Mar;38:210-11.

Terao T, Yoshimura R, Shiratuchi T, Abe K. Effects of lithium on steroid-induced depression. Biolog Psych. 1997;41(12):1225-6.

Putignano P, Kaltsas GA, Satta MA, Grossman AB. The effects of anti-convulsant drugs on adrenal function. Horm Metab Res. 1998;30(06/07):389-97.

Patsalos PN, Duncan JS. Antiepileptic drugs. Drug Saf. 1993 Sep 1;9(3):156-84.

Himelhoch S, Haller E. Extreme mood lability associated with systemic lupus erythematosus and stroke successfully treated with valproic acid. J Clini Psychopharmacol. 1996 Dec 1;16(6):469-70.

Blazer DG, Petrie WM, Wilson WP. Affective psychosis following renal transplant. Dis Nerv Syst. 1976;37:663-7.

Silva RG, Tolstunov L. Steroid-induced psychosis: report of case. J Oral Maxillofac Surg. 1995 Feb 1;53(2):183-6.

Baloch N. ‘Steroid psychosis’: a case report. The Br J Psych. 1974 Jun;124(583):545-6.

Brown ES, Khan DA, Suppes T. Treatment of corticosteroid-induced mood changes with olanzapine. Am J Psych. 1999 Jun 1;156(6):968.

Wyszynski AA, Wyszynski B. Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system’s Sjogren's syndrome. Psychosomat. 1993;34:173-7.

Antipsychotics. Available at: Merckmanual.com. www.merckmanuals.com/professional/geriatrics/drug-therapy-in-the-elderly/drug-categories-of-concern-in-the-elderly. Accessed 7 June 2016.

Semla TP, Beizer JL, Higbee MD. Geriatric Dosage Handbook. 20th ed. Hudson, OH: Lexicomp; 2015: 942-945.

Epocrates Plus Version 15.12.1. Updated May 9. Available at: Epocrates.com. 2016. Accessed 15 June 2016.

Magariños AM, McEwen BS, Flügge G, Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci. 1996 May 15;16(10):3534-40.

Magariños AM, Deslandes A, McEwen BS. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol. 1999 Apr 29;371(2-3):113-22.